Scarica l'app Stockscreener
9.71
0.21%
-0.02
Pre-mercato:
9.68
-0.03
-0.31%
Regenxbio Inc Borsa (RGNX) Ultime notizie
Regenxbio Inc (RGNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Price to book ratio of REGENXBIO, Inc. – HAM:RB0 - TradingView
Inventory turnover of REGENXBIO, Inc. – HAM:RB0 - TradingView
Regenxbio Inc (RGNX) Cash Flow - TradingKey
Regenxbio Inc (RGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
RGNX|Regenxbio Inc|Price:9.730|Chg%:-0.520 - TradingKey
Regenxbio Inc (RGNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy - Stocktwits
Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy - Stocktwits
RGNX Stock Slumps 15% After-Hours — What’s Driving The Selloff? - Stocktwits
REGENXBIO Inc. (RGNX) stock price, news, quote and history - Yahoo Finance Australia
REGENXBIO Inc. Revenue Breakdown – NASDAQ:RGNX - TradingView
Regenxbio Inc (RGNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Matt Wilsey Built a Gene Therapy for His Daughter. He Says the FDA Isn't Ready for What Comes Next. - finance.biggo.com
REGENXBIO Inc. (RGNX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lawsuit alleges Regenxbio misled investors on g... - Pluang
Kuehn Law Encourages Investors of Regenxbio, Inc. to Contact Law Firm - Morningstar
RegenXBio Raises Capital Through Public Equity Offering - The Globe and Mail
(RGNX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Clinical Trial Results Show Extended Benefits for REGENXBIO Retinal Treatments - Benzinga
REGENXBIO Raises $100 Million in Public Offering of Common Stock and Pre-Funded Warrants - Minichart
REGENXBIO (NASDAQ: RGNX) prices stock and warrant sale, netting $107.8M - Stock Titan
Regenxbio prices expected $100M public offering - The Pharma Letter
Regenxbio (RGNX) Reports Positive Long-Term Results for Gene The - GuruFocus
Frontier tech research, news & data - MLQ.ai
Regenxbio (RGNX) Reports Positive Long-Term Results for Gene Therapy in Eye Conditions - GuruFocus
Regenxbio reports 5-year wet AMD efficacy data for sura-vec gene therapy at ASRS meeting - Bitget
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting - PR Newswire
RGNX Stock Sinks After $100M Equity Deal Hits Sentiment - timothysykes.com
REGENXBIO Stock Slides After $100M Equity Offering Pricing - timothysykes.com
REGENXBIO Stock Slides After $100M Equity Offering Shock - StocksToTrade
Form 424B5 Regenxbio Inc For: 17 July By Investing.com - Investing.com Australia
Regenxbio prices $100m public offering at $9 per share By Investing.com - Investing.com South Africa
Form 424B5 Regenxbio Inc For: 17 July - Investing.com UK
REGENXBIO (RGNX) Launches $100M Public Offering at $9.00 per Sha - GuruFocus
REGENXBIO stock dips on $100M equity offering - MSN
Regenxbio Shares Fall on $100M Stock, Pre-Funded Warrant Offering - Moomoo
REGENXBIO (NASDAQ: RGNX) launches $100M equity and pre-funded warrant raise - Stock Titan
Regenxbio (RGNX) Launches $100 Million Public Offering - GuruFocus
RGNX Stock Slides As $100M Offering And Legal Heat Hit - StocksToTrade
REGENXBIO Prices $100 Million Public Offering - Moomoo
Crude Oil Surges 4%; Travelers Posts Upbeat Q2 results - Benzinga
RGNX Stock Dips As Equity Offering And Litigation Raise Risk - timothysykes.com
REGENXBIO raises USD 100m amid pivotal year for gene therapy pipeline - AllSci
REGENXBIO files prospectus for up to $100M common stock offering - MSN
Gene Therapy Pioneer REGENXBIO Prices Public Offering, Aims to Raise $100 Million - finance.biggo.com
Regenxbio prices $100m public offering at $9 per share - Investing.com
REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants - PR Newswire
Why is Regenxbio stock falling sharply today? - Investing.com
RGNX stock slumps 15% after-hours — what’s driving the selloff? - MSN
Form 424B5 Regenxbio Inc For: 16 July - Investing.com UK
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):